Archive: 2025/12 - Page 2

Ordering medication from foreign websites may save money, but it puts your life at risk. Counterfeit drugs are widespread, often deadly, and nearly impossible to detect. Learn how to avoid them and stay safe.

Expired medications aren't always dangerous, but they're rarely reliable. Learn which pills are safe to use after expiration, which ones can harm you, and how to store and dispose of them properly.

Learn how to talk to your doctor about generic vs. brand-name medications-when generics work just as well, when to ask for the brand, and how to save money without risking your health.

NTI generics require stricter regulation than standard generics due to narrow margins between effective and toxic doses. This article explores how the FDA, EMA, Canada, and Japan differ in their approaches, what’s changing in 2025, and why prescribers must stay cautious.

Supportive care in cancer uses growth factors, antiemetics, and pain relief to manage treatment side effects, improve survival, and keep patients on track. Learn how these evidence-based tools work and why access remains unequal.

In 2025, the U.S. government expanded its drug shortage response with a new API stockpile program, but gaps in enforcement, funding, and economic incentives leave hospitals and patients vulnerable to ongoing shortages of critical medications.

Tentative FDA approval for generics means the drug is scientifically ready - but legal, manufacturing, or economic barriers often block its market launch. Here's why so many generics never reach patients.

The FDA doesn't stop monitoring generic drugs after approval. Using real-time data, inspections, and patient reports, it tracks safety issues long after these affordable medications hit the market. Here's how it works.

Checkpoint inhibitors and CAR-T cell therapy are transforming cancer treatment by harnessing the immune system. Learn how they work, who benefits most, their side effects, and why access remains unequal.